{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:41:31Z","timestamp":1786981291296,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["EKFS, 2017_A110"],"award-info":[{"award-number":["EKFS, 2017_A110"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009417","name":"Care-for-Rare Foundation","doi-asserted-by":"publisher","award":["C4R, 160073"],"award-info":[{"award-number":["C4R, 160073"]}],"id":[{"id":"10.13039\/100009417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1910C"],"award-info":[{"award-number":["01GM1910C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bi-allelic variants in the dedicator of cytokinesis 8 (\n                    <jats:italic>DOCK8<\/jats:italic>\n                    ) gene cause a combined immunodeficiency, characterized by recurrent sinopulmonary and skin infections, food allergies, eczema, eosinophilia, and elevated IgE. Long-term outcome is poor given susceptibility to infections, malignancy, and vascular complications. Allogeneic hematopoietic stem cell transplantation is currently the only curative treatment option and has shown promising outcome. The impact of mixed chimerism on long-term outcome is unclear. We reasoned that reversal of disease phenotype would depend on cell lineage-specific chimerism.\n                    <jats:italic>DOCK8<\/jats:italic>\n                    variants were confirmed by Sanger and\/or exome sequencing and immunoblot and\/or intracellular flow cytometry. Donor chimerism was analyzed by XY-fluorescence in situ hybridization or quantitative short tandem repeat PCR. Outcome was assessed by laboratory tests, lymphocyte subsets, intracellular DOCK8 protein flow cytometry, T-cell proliferation analysis, and multiparameter immunoblot allergy screening. We report on nine patients, four of whom with mixed chimerism, with a median follow-up of 78\u00a0months after transplantation. Overall, we report successful transplantation with improvement of susceptibility to infections and allergies, and resolution of eczema in all patients. Immunological outcome in patients with mixed chimerism suggests a selective advantage for wild-type donor T-cells but lower donor B-cell chimerism possibly results in a tendency to hypogammaglobulinemia. No increased infectious and allergic complications were associated with mixed chimerism. Aware of the relatively small cohort size, we could not demonstrate a consistent detrimental effect of mixed chimerism on clinical outcomes. We nevertheless advocate aiming for complete donor chimerism in treating DOCK8 deficiency, but recommend reduced toxicity conditioning.\n                  <\/jats:p>","DOI":"10.1007\/s10875-021-01069-5","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T18:04:35Z","timestamp":1622657075000},"page":"1536-1548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Lineage-Specific Chimerism and Outcome After Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency"],"prefix":"10.1007","volume":"41","author":[{"given":"Johannes","family":"Raedler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Magg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meino","family":"Rohlfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Hauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9143-3263","authenticated-orcid":false,"given":"Michael H.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"issue":"21","key":"1069_CR1","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","volume":"361","author":"Q Zhang","year":"2009","unstructured":"Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361(21):2046\u201355.","journal-title":"N Engl J Med"},{"issue":"2","key":"1069_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","volume":"35","author":"SE Aydin","year":"2015","unstructured":"Aydin SE, Kilic SS, Aytekin C, Kumar A, Porras O, Kainulainen L, et al. DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients. J Clin Immunol. 2015;35(2):189\u201398.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1069_CR3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jaci.2014.12.1945","volume":"136","author":"KR Engelhardt","year":"2015","unstructured":"Engelhardt KR, Gertz ME, Keles S, Sch\u00e4ffer AA, Sigmund EC, Glocker C, et al. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2015;136(2):402\u201312.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1069_CR4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","volume":"124","author":"KR Engelhardt","year":"2009","unstructured":"Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124(6):1289-302.e4.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1069_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10875-016-0296-z","volume":"36","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Jing H, Su HC. Recent advances in DOCK8 immunodeficiency syndrome. J Clin Immunol. 2016;36(5):441\u20139.","journal-title":"J Clin Immunol"},{"key":"1069_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clim.2017.06.003","volume":"181","author":"CM Biggs","year":"2017","unstructured":"Biggs CM, Keles S, Chatila TA. DOCK8 deficiency: insights into pathophysiology, clinical features and management. Clin Immunol. 2017;181:75\u201382.","journal-title":"Clin Immunol"},{"issue":"3","key":"1069_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jaci.2016.07.016","volume":"139","author":"SG Tangye","year":"2017","unstructured":"Tangye SG, Pillay B, Randall KL, Avery DT, Phan TG, Gray P, et al. Dedicator of cytokinesis 8-deficient CD4(+) T cells are biased to a T(H)2 effector fate at the expense of T(H)1 and T(H)17 cells. J Allergy Clin Immunol. 2017;139(3):933\u201349.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1069_CR8","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.jaci.2014.03.025","volume":"133","author":"H Jing","year":"2014","unstructured":"Jing H, Zhang Q, Zhang Y, Hill BJ, Dove CG, Gelfand EW, et al. Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype. J Allergy Clin Immunol. 2014;133(6):1667\u201375.","journal-title":"J Allergy Clin Immunol"},{"key":"1069_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clim.2015.12.003","volume":"163","author":"AK Kienzler","year":"2016","unstructured":"Kienzler AK, van Schouwenburg PA, Taylor J, Marwah I, Sharma RU, Noakes C, et al. Hypomorphic function and somatic reversion of DOCK8 cause combined immunodeficiency without hyper-IgE. Clin Immunol. 2016;163:17\u201321.","journal-title":"Clin Immunol"},{"issue":"3\u20134","key":"1069_CR10","first-page":"131","volume":"29","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Davis JC, Dove CG, Su HC. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Dis Markers. 2010;29(3\u20134):131\u20139.","journal-title":"Dis Markers"},{"issue":"6","key":"1069_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/ni.2305","volume":"13","author":"HH Jabara","year":"2012","unstructured":"Jabara HH, McDonald DR, Janssen E, Massaad MJ, Ramesh N, Borzutzky A, et al. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat Immunol. 2012;13(6):612\u201320.","journal-title":"Nat Immunol"},{"key":"1069_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fped.2019.00451","volume":"7","author":"MH Albert","year":"2019","unstructured":"Albert MH, Freeman AF. Wiskott-Aldrich syndrome (WAS) and dedicator of Cytokinesis 8- (DOCK8) Deficiency. Front Pediatr. 2019;7:451.","journal-title":"Front Pediatr"},{"key":"1069_CR13","doi-asserted-by":"publisher","first-page":"14209","DOI":"10.1038\/ncomms14209","volume":"8","author":"T Schober","year":"2017","unstructured":"Schober T, Magg T, Laschinger M, Rohlfs M, Linhares ND, Puchalka J, et al. A human immunodeficiency syndrome caused by mutations in CARMIL2. Nat Commun. 2017;8:14209.","journal-title":"Nat Commun"},{"issue":"7","key":"1069_CR14","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.4049\/jimmunol.1202792","volume":"190","author":"H Ham","year":"2013","unstructured":"Ham H, Guerrier S, Kim J, Schoon RA, Anderson EL, Hamann MJ, et al. Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity. J Immunol (Baltimore, Md: 1950). 2013;190(7):3661\u20139.","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"1069_CR15","doi-asserted-by":"publisher","first-page":"151413","DOI":"10.1016\/j.anndiagpath.2019.151413","volume":"43","author":"D Kim","year":"2019","unstructured":"Kim D, Uner A, Saglam A, Chadburn A, Crane GM. Peripheral eosinophilia in primary immunodeficiencies of actin dysregulation: a case series of Wiskott-Aldrich syndrome, CARMIL2 and DOCK8 deficiency and review of the literature. Ann Diagn Pathol. 2019;43:151413.","journal-title":"Ann Diagn Pathol"},{"key":"1069_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.coi.2014.01.015","volume":"28","author":"A Kane","year":"2014","unstructured":"Kane A, Deenick EK, Ma CS, Cook MC, Uzel G, Tangye SG. STAT3 is a central regulator of lymphocyte differentiation and function. Curr Opin Immunol. 2014;28:49\u201357.","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"1069_CR17","doi-asserted-by":"publisher","first-page":"e28084","DOI":"10.1002\/pbc.28084","volume":"67","author":"Z Aryan","year":"2020","unstructured":"Aryan Z, Nabavi M, Shabani M, Keles S, Zoghi S, Chatila T, et al. Hypomorphic DOCK8 deletion causes hypereosinophilic syndrome. Pediatr Blood Cancer. 2020;67(2):e28084.","journal-title":"Pediatr Blood Cancer"},{"issue":"16","key":"1069_CR18","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1608\u201319.","journal-title":"N Engl J Med"},{"issue":"3","key":"1069_CR19","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jaci.2016.02.022","volume":"138","author":"W Al-Herz","year":"2016","unstructured":"Al-Herz W, Chu JI, van der Spek J, Raghupathy R, Massaad MJ, Keles S, et al. Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2016;138(3):852-9 e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1069_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-0030-1265135","volume":"222","author":"TC Bittner","year":"2010","unstructured":"Bittner TC, Pannicke U, Renner ED, Notheis G, Hoffmann F, Belohradsky BH, et al. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin Padiatr. 2010;222(6):351\u20135.","journal-title":"Klin Padiatr"},{"issue":"6","key":"1069_CR21","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jaci.2010.07.034","volume":"126","author":"DR McDonald","year":"2010","unstructured":"McDonald DR, Massaad MJ, Johnston A, Keles S, Chatila T, Geha RS, et al. Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2010;126(6):1304-5.e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1069_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.bbmt.2017.03.016","volume":"23","author":"NN Shah","year":"2017","unstructured":"Shah NN, Freeman AF, Su H, Cole K, Parta M, Moutsopoulos NM, et al. Haploidentical related donor hematopoietic stem cell transplantation for dedicator-of-cytokinesis 8 deficiency using post-transplantation cyclophosphamide. Biol Blood Marrow Transplant. 2017;23(6):980\u201390.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"1069_CR23","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jaip.2018.10.035","volume":"7","author":"SE Aydin","year":"2019","unstructured":"Aydin SE, Freeman AF, Al-Herz W, Al-Mousa HA, Arnaout RK, Aydin RC, et al. Hematopoietic stem cell transplantation as treatment for patients with DOCK8 deficiency. J Allergy Clin Immunol Pract. 2019;7(3):848\u201355.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"1069_CR24","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/bmt.2015.171","volume":"50","author":"MA Slatter","year":"2015","unstructured":"Slatter MA, Boztug H, P\u00f6tschger U, Sykora KW, Lankester A, Yaniv I, et al. Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases. Bone Marrow Transplant. 2015;50(12):1536\u201341.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"1069_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bbmt.2017.11.009","volume":"24","author":"MA Slatter","year":"2018","unstructured":"Slatter MA, Rao K, Abd Hamid IJ, Nademi Z, Chiesa R, Elfeky R, et al. Treosulfan and fludarabine conditioning for hematopoietic stem cell transplantation in children with primary immunodeficiency: UK experience. Biol Blood Marrow Transplant. 2018;24(3):529\u201336.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"25","key":"1069_CR26","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1182\/blood-2015-12-684498","volume":"127","author":"B Hartz","year":"2016","unstructured":"Hartz B, Marsh R, Rao K, Henter JI, Jordan M, Filipovich L, et al. The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis. Blood. 2016;127(25):3281\u201390.","journal-title":"Blood"},{"issue":"6","key":"1069_CR27","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1182\/blood-2010-11-319376","volume":"118","author":"D Moratto","year":"2011","unstructured":"Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980\u20132009: an international collaborative study. Blood. 2011;118(6):1675\u201384.","journal-title":"Blood"},{"key":"1069_CR28","doi-asserted-by":"crossref","unstructured":"Haskologlu S, Kostel Bal S, Islamoglu C, Aytekin C, Guner S, Sevinc S, et al. Clinical, immunological features and follow up of 20 patients with dedicator of cytokinesis 8 (DOCK8) deficiency. Pediatr Allergy Immunol. 2020;31(5):515\u201327.","DOI":"10.1111\/pai.13236"},{"key":"1069_CR29","doi-asserted-by":"crossref","unstructured":"Pillay BA, Avery DT, Smart JM, Cole T, Choo S, Chan D, et al. Hematopoietic stem cell transplant effectively rescues lymphocyte differentiation and function in DOCK8-deficient patients. JCI Insight. 2019;5(11):e127527.","DOI":"10.1172\/jci.insight.127527"},{"issue":"11","key":"1069_CR30","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1084\/jem.20110345","volume":"208","author":"KL Randall","year":"2011","unstructured":"Randall KL, Chan SS, Ma CS, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208(11):2305\u201320.","journal-title":"J Exp Med"},{"issue":"12","key":"1069_CR31","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1002\/eji.201141759","volume":"41","author":"T Lambe","year":"2011","unstructured":"Lambe T, Crawford G, Johnson AL, Crockford TL, Bouriez-Jones T, Smyth AM, et al. DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory. Eur J Immunol. 2011;41(12):3423\u201335.","journal-title":"Eur J Immunol"},{"key":"1069_CR32","doi-asserted-by":"crossref","unstructured":"Pillay BA, Fusaro M, Gray PE, Statham AL, Burnett L, Bezrodnik L, et al. Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency. J Clin Invest. 2021;131(3):e142434.","DOI":"10.1172\/JCI142434"},{"issue":"12","key":"1069_CR33","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/ni.1820","volume":"10","author":"KL Randall","year":"2009","unstructured":"Randall KL, Lambe T, Johnson AL, Treanor B, Kucharska E, Domaschenz H, et al. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nat Immunol. 2009;10(12):1283\u201391.","journal-title":"Nat Immunol"},{"key":"1069_CR34","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3389\/fimmu.2019.00782","volume":"10","author":"NG van der Maas","year":"2019","unstructured":"van der Maas NG, Berghuis D, van der Burg M, Lankester AC. B cell reconstitution and influencing factors after hematopoietic stem cell transplantation in children. Front Immunol. 2019;10:782.","journal-title":"Front Immunol"},{"issue":"26","key":"1069_CR35","doi-asserted-by":"publisher","first-page":"6824","DOI":"10.1182\/blood-2011-06-362533","volume":"118","author":"M Recher","year":"2011","unstructured":"Recher M, Berglund LJ, Avery DT, Cowan MJ, Gennery AR, Smart J, et al. IL-21 is the primary common \u03b3 chain-binding cytokine required for human B-cell differentiation in vivo. Blood. 2011;118(26):6824\u201335.","journal-title":"Blood"},{"issue":"6","key":"1069_CR36","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.jaci.2015.11.017","volume":"137","author":"CS Happel","year":"2016","unstructured":"Happel CS, Stone KD, Freeman AF, Shah NN, Wang A, Lyons JJ, et al. Food allergies can persist after myeloablative hematopoietic stem cell transplantation in dedicator of cytokinesis 8-deficient patients. J Allergy Clin Immunol. 2016;137(6):1895-8.e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1069_CR37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jaci.2011.03.025","volume":"128","author":"V Barlogis","year":"2011","unstructured":"Barlogis V, Galambrun C, Chambost H, Lamoureux-Toth S, Petit P, Stephan JL, et al. Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency. J Allergy Clin Immunol. 2011;128(2):420-22.e2.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1069_CR38","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1399-3046.2011.01641.x","volume":"16","author":"A Metin","year":"2012","unstructured":"Metin A, Tavil B, Azik F, Azkur D, Ok-Bozkaya I, Kocabas C, et al. Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome. Pediatr Transplant. 2012;16(4):398\u20139.","journal-title":"Pediatr Transplant"},{"issue":"6","key":"1069_CR39","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jaci.2014.07.042","volume":"134","author":"E Janssen","year":"2014","unstructured":"Janssen E, Morbach H, Ullas S, Bannock JM, Massad C, Menard L, et al. Dedicator of cytokinesis 8\u2013deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells. J Allergy Clin Immunol. 2014;134(6):1365\u201374.","journal-title":"J Allergy Clin Immunol"},{"key":"1069_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000323305","volume":"41","author":"R Agrawal","year":"2011","unstructured":"Agrawal R, Wisniewski JA, Woodfolk JA. The role of regulatory T cells in atopic dermatitis. Curr Probl Dermatol. 2011;41:112\u201324.","journal-title":"Curr Probl Dermatol"},{"key":"1069_CR41","doi-asserted-by":"crossref","unstructured":"Jacob M, Gu X, Luo X, Al-Mousa H, Arnaout R, Al-Saud B, et al. Metabolomics distinguishes DOCK8 deficiency from atopic dermatitis: towards a biomarker discovery. Metabolites. 2019;9(11):274.","DOI":"10.3390\/metabo9110274"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01069-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-021-01069-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01069-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T15:02:39Z","timestamp":1632150159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-021-01069-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-01069-5","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,2]]},"assertion":[{"value":"21 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All caretakers consented to data collection via the German pediatric registry for stem cell transplantation (\u201cP\u00e4diatrisches Register f\u00fcr Stammzelltransplantation\u201d, PRST), which was approved by the ethics committee of the MHH, Hannover, Germany and by the local ethics committee of LMU, Munich.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed written consent about this data analysis and publication was obtained from all individual participants or respective legal guardians included in the study, except for patient 4 who was lost to follow-up and could not be reached.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"See above.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"MA declares travel support by Medac. All other authors have no conflict of interest to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}